| 000 | 01860 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514011127.0 | ||
| 264 | 0 | _c20011207 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0165-0270 | ||
| 024 | 7 |
_a10.1016/s0165-0270(01)00427-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHermanns, S | |
| 245 | 0 | 0 |
_aA reliable method to reduce collagen scar formation in the lesioned rat spinal cord. _h[electronic resource] |
| 260 |
_bJournal of neuroscience methods _cSep 2001 |
||
| 300 |
_a141-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2,2'-Dipyridyl _xpharmacology |
| 650 | 0 | 4 |
_a8-Bromo Cyclic Adenosine Monophosphate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasement Membrane _xdrug effects |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 |
_aCicatrix _xetiology |
| 650 | 0 | 4 |
_aCollagen Type IV _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aExtracellular Matrix _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGliosis _xetiology |
| 650 | 0 | 4 |
_aIndicators and Reagents _xpharmacology |
| 650 | 0 | 4 |
_aIron _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Regeneration _xdrug effects |
| 650 | 0 | 4 |
_aProcollagen-Proline Dioxygenase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
| 650 | 0 | 4 |
_aSpinal Cord Injuries _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aReiprich, P | |
| 700 | 1 | _aMüller, H W | |
| 773 | 0 |
_tJournal of neuroscience methods _gvol. 110 _gno. 1-2 _gp. 141-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-0270(01)00427-7 _zAvailable from publisher's website |
| 999 |
_c11486572 _d11486572 |
||